Classical Monocyte Kinetics in Chronic Myelomonocytic Leukemia
NCT04775121 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39
Last updated 2024-05-24
Summary
To measure the rate of bone marrow release and the lifespan of classical monocytes in the peripheral blood of patients with a chronic myelomonocytic leukemia
Conditions
- Myelomonocytic Leukemia
Interventions
- OTHER
-
Deuterium Glucose
Oral administration of 20 g Deuterium Glucose on a 3-hour
Sponsors & Collaborators
-
Gustave Roussy, Cancer Campus, Grand Paris
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-05-13
- Primary Completion
- 2023-11-04
- Completion
- 2023-11-04
Countries
- France
Study Locations
More Related Trials
-
Natural Killer Cells in Older Patients With Acute Myeloid Leukemia
NCT00540956 ·Status: COMPLETED ·Phase: NA
-
Treatment of Acute Myeloblastic Leukemia in Younger Patients
NCT00390715 ·Status: COMPLETED
-
Chronic Myeloid Leukemia (CML) Real-Life Database
NCT05963061 ·Status: RECRUITING
-
Dasatinib for Patients Achieving Complete Molecular Response for Cure D-NewS Trial
NCT01887561 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Treatment Free Remission in Patients With Chronic Myeloid Leukemia in Chronic Phase
NCT05926128 ·Status: UNKNOWN ·Phase: NA
-
A Study of Complete Molecular Response for Chronic Myeloid Leukemia in Chronic Phase Patients, Treated With Dasatinib
NCT01342679 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
NCT00287105 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Bosutinib in Japanese Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
NCT03128411 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Imatinib in Chronic Myelogenous Patients Older Than 70 Years
NCT00219752 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Combination of a Tyrosine Kinase Inhibitor (STI571) and a Pegylated Human Recombinant Interferon alfa2b (PEGINTRON)
NCT00511121 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Toxicity of Blinatumomab in the French ATU for Adult BCP-ALL R/R, or With MRD+ (FRENCH-CYTO)
NCT03751072 ·Status: COMPLETED
-
Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid Leukemia
NCT00497991 ·Status: COMPLETED ·Phase: PHASE1
-
Frontline Asciminib Combination in Chronic Phase CML
NCT03906292 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Clinical Outcomes of 3L+ Therapies Among Patients With Chronic Myeloid Leukemia and Those With T315I Mutation
NCT05611216 ·Status: COMPLETED
-
CPX-351 vs Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics
NCT05260528 ·Status: RECRUITING ·Phase: PHASE2
-
A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status
NCT00462761 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Dasatinib in Patients With Core Binding Factors Acute Myelogenous Leukemia
NCT02113319 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of CPX-351 Monotherapy in Acute Myeloid Leukemia Secondary to Myeloproliferative Neoplasm
NCT04992949 ·Status: COMPLETED ·Phase: PHASE2
-
Therapy of Early Chronic Phase CML With Higher-Dose Gleevec, Alpha Interferon, and Low-Dose Ara-C
NCT00038649 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Treatment-free Remission in Chronic Phase Chronic Myeloid Leukemia
NCT06368414 ·Status: RECRUITING ·Phase: PHASE2
-
Dasatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia in Japan
NCT01464411 ·Status: UNKNOWN
-
Combination of an Anti-PD1 Antibody With Tisagenlecleucel Reinfusion in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia After Loss of Persistence
NCT05310591 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Assess Long-term Feasibility of Reduced Dose Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients
NCT04150471 ·Status: UNKNOWN
-
Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
NCT04925479 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase I, Dose-finding Study of BEZ235 in Adult Patients With Relapsed or Refractory Acute Leukemia
NCT01756118 ·Status: COMPLETED ·Phase: PHASE1